Salesforce stock has slumped amid SaaSpocalypse concerns: what next?

Salesforce shares are down more than 50% from the December 2024 peak, pulling market cap from $347B+ to about $136B. The decline is driven by growing investor concern over the company’s growth outlook and strategy for long-term performance, with further downside possible if sentiment does not improve.

Analysis

The main implication is not that enterprise software is broken; it is that the market is repricing CRM from a “platform compounder” to a slower, cash-generative mature software asset. That change in multiple regime matters more than near-term revenue deltas: once growth durability is questioned, each incremental slowdown can compress EV/revenue faster than the fundamentals deteriorate. The first-order losers are CRM shareholders, but the second-order pressure likely spills into adjacent large-cap SaaS names where investors have tolerated premium valuations on the assumption that share gains can offset macro softness.

From a competitive standpoint, the biggest beneficiary is not a single direct rival so much as the suite vendors with broader budget control. Microsoft and Oracle can bundle customer-facing workflows into larger contracts, making it harder for standalone CRM spend to defend pricing. That said, the broader risk is more ominous for the sector: if customers are trimming multi-year transformation projects, implementation partners and consultants see slower backlog conversion before software revenue actually rolls over.

The setup is tricky because the stock has already de-rated aggressively, so the easy money in a structural short may be mostly gone unless there is another leg down in bookings, remaining performance obligations, or guidance. Near term, the path of least resistance is still downward if management cannot show stabilization in net retention or billings growth; over 6-18 months, the key question is whether free-cash-flow growth can outrun revenue deceleration enough to justify a lower but stable multiple. The contrarian risk is that consensus may be underestimating the durability of the installed base and the company’s ability to defend margin through slower hiring and buybacks; if those hold, downside from here becomes more about valuation than collapse.

What would invalidate the bearish view is a clean re-acceleration in core renewal metrics or a credible product-led catalyst that translates into a better 1-2 quarter bookings trajectory. Absent that, this looks more like a “sell rallies” name than an outright momentum short, because the stock has likely already discounted a meaningful amount of bad news and is vulnerable to any hint of stabilization.

Key Decisions for Investors

• Avoid initiating fresh outright shorts into weakness; wait for a rally back toward prior support or a post-earnings relief bounce, then short CRM with a 1-3 month horizon and a stop above any guidance-reset rebound.
• For cleaner risk/reward, use a CRM put spread into the next earnings/catalyst window rather than naked puts; the thesis only works if management fails to show billings or RPO stabilization, and theta decay is a real risk after a 50% drawdown.
• Pair trade: short CRM / long MSFT on a 1-3 month basis if you want to express relative budget-share migration toward bundled enterprise suites; the key check is whether Microsoft’s commercial cloud growth remains resilient while CRM’s growth multiple compresses further.
• Watch for a fundamental falsifier: any sequential improvement in billings, cRPO, or forward guidance on current-quarter growth. If those inflect, cover shorts quickly because the stock can re-rate violently on even modest stabilization.
• If looking for a contrarian long, prefer only a small starter position after confirmation that FCF margin can offset slower top-line growth; otherwise CRM is better viewed as a valuation-trap candidate than a deep-value opportunity.